{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:28:52Z","timestamp":1781422132293,"version":"3.54.1"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["BIOT"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Peptide-based therapy has emerged as a promising avenue for\ntreating various disorders, and recent research has highlighted the potential of anti-cancer\npeptides (ACPs) in cancer treatment. In this context, this study aimed to design a novel\npeptide incorporating a tumor-homing peptide (RGD) and C-amidation to enhance its anticancer\nactivity, particularly against liver (HepG2) and colon (HCT-116) cancer cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The primary objective was to design a peptide with improved anticancer\nproperties by leveraging the tumor-homing capabilities of RGD and enhancing its activity\nthrough C-amidation. The study sought to evaluate the cytotoxicity of the designed\npeptide against red blood cells (RBCs) and normal Vero cells. Furthermore, the anticancer\nefficacy of the peptide was assessed in hepatocellular carcinoma (HepG2) and colon\ncancer (HCT-116) cell lines. The specific objectives included examining the apoptotic\ninduction and morphological changes in treated cells compared to untreated cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The peptide was designed using the ACPred-FL bioinformatics tool, and its\ncytotoxicity was assessed through hemolysis assays against RBCs and normal Vero cells.\nAnticancer activity was evaluated against HepG2 and HCT-116 cell lines. The analysis\nof apoptotic induction involved measuring the relative gene expression of oncogenic\nmarker BCL2 and apoptotic markers (BAX, BID, CAS-8). Additionally, Cytopathological\nexamination and Western Blot analysis were employed to study morphological\nchanges and confirm the quantification of relevant markers.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The designed peptide, consisting of twelve amino acids with a molecular mass\nof 1230.6233 Da and an isoelectric point of 9.81, exhibited low erythrocyte lysis and\nminimal toxicity to normal cells. The IC50 values demonstrated significant anticancer activity\nagainst both HepG2 (36.49\u00b12.6 \u03bcg\/mL) and HCT-116 (11.03\u00b12.5 \u03bcg\/mL) cell\nlines. Treated cells exhibited a significant decrease in the oncogenic marker BCL2 and an\nupregulation of apoptotic markers (BAX, BID, CAS-8). Western Blot analysis confirmed\nthese results in addition to cytopathological examination that scattered apoptotic and degenerative\nchanges.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The designed peptide is considered a patent product that displayed remarkable\nanticancer activity against hepatocellular carcinoma and colon cancer cell lines, effectively\nmodulating apoptotic and oncogenic markers. These findings highlight the potential of the\npeptide as a therapeutic agent for cancer treatment, emphasizing its clinical significance in\ncombating liver and colon cancers. Nonetheless, further research and development are warranted\nto explore the translational potential of this peptide in clinical studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118722083300452240315035722","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T07:22:57Z","timestamp":1711351377000},"page":"128-141","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a Novel Peptide with RGD Tumor Homing Motif: Evaluation of its Anticancer Potential in Hepatocellular Carcinoma and Colon Cancer Cells"],"prefix":"10.2174","volume":"19","author":[{"given":"Reda Abdallah","family":"Mohamed","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-8476","authenticated-orcid":true,"given":"Ohoud Mohammed","family":"Marie","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia Ibrahim","family":"Badran","sequence":"additional","affiliation":[{"name":"Department of\nMedical Biochemistry, Faculty of Medicine, Suez Canal University, Ismailia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4965-5804","authenticated-orcid":true,"given":"Olfat Ali","family":"Hammam","sequence":"additional","affiliation":[{"name":"Department of Pathology,\nTheodor Bilharz Research Institute, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-245X","authenticated-orcid":true,"given":"Hend Okasha","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology,\nTheodor Bilharz Research Institute, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1201\/b12951","author":"Kinsella N.","year":"2012","unstructured":"Kinsella N.;  Registration of peptides and proteins Pharmaceutical Formulation Development of Peptides and Proteins  2012,339-366","journal-title":"Registration of peptides and proteins Pharmaceutical Formulation Development of Peptides and Proteins"},{"key":"ref=2","first-page":"6","volume":"31","author":"Grigolava M.","year":"2015","unstructured":"Grigolava M.; Vishnepolsky B.; Pirtskhalava M.; Antimicrobial peptides as anticancer agents. Biopolymers Cell  2015,31(5),6","journal-title":"Biopolymers Cell"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","volume":"250","author":"Dissanayake S.","year":"2017","unstructured":"Dissanayake S.; Denny W.A.; Gamage S.; Sarojini V.; Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J Control Release  2017,250,62-76","journal-title":"J Control Release"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/molecules25040808","volume":"25","author":"Scodeller P.","year":"2020","unstructured":"Scodeller P.; Asciutto E.K.; Targeting tumors using peptides. Molecules  2020,25(4),808","journal-title":"Molecules"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/jacs.2c12497","volume":"145","author":"Thoma B.","year":"2023","unstructured":"Thoma B.; Powner M.W.; Selective synthesis of lysine peptides and the prebiotically plausible synthesis of catalytically active diaminopropionic acid peptide nitriles in water. J Am Chem Soc  2023,145(5),3121-3130","journal-title":"J Am Chem Soc"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/757838","volume":"2012","author":"Hayashi M.A.F.","year":"2012","unstructured":"Hayashi M.A.F.; Ducancel F.; Konno K.; Natural peptides with potential applications in drug development, diagnosis, and\/or biotechnology. Int J Pept  2012,2012,1-2","journal-title":"Int J Pept"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/761820","volume":"2015","author":"Xiao Y.F.","year":"2015","unstructured":"Xiao Y.F.; Jie M.M.; Li B.S.; Peptide-based treatment: A promising cancer therapy. J Immunol Res  2015,2015,1-13","journal-title":"J Immunol Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1021\/mp3002733","volume":"9","author":"Danhier F.","year":"2012","unstructured":"Danhier F.; Le Breton A.; Pr\u00e9at V.; RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm  2012,9(11),2961-2973","journal-title":"Mol Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00249-015-1094-x","volume":"45","author":"Mura M.","year":"2016","unstructured":"Mura M.; Wang J.; Zhou Y.; The effect of amidation on the behaviour of antimicrobial peptides. Eur Biophys J  2016,45(3),195-207","journal-title":"Eur Biophys J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"Heimbach J.K.","year":"2018","unstructured":"Heimbach J.K.; Kulik L.M.; Finn R.S.; AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology  2018,67(1),358-380","journal-title":"Hepatology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"125420","DOI":"10.1016\/j.ijbiomac.2023.125420","volume":"245","author":"Rashdan H.R.M.","year":"2023","unstructured":"Rashdan H.R.M.; Okasha H.; Salem M.M.; Abd El-Hady B.M.; Ekram B.; Investigation of novel HCV therapies: Boscia angustifalia and Boscia senegalensis extracts loaded on galactosylated chitosan nanoparticles synthesized by eco-friendly method for HCV treatment. Int J Biol Macromol  2023,245,125420","journal-title":"Int J Biol Macromol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"024","DOI":"10.1016\/j.jcol.2017.09.418","volume":"38","author":"Metwally IH","year":"2018","unstructured":"Metwally IH; Shetiwy M; Elalfy AF; Abouzid A; Saleh SS; Hamdy M; Epidemiology and survival of colon cancer among Egyptians: A retrospective study. J Coloproctol (Rio J)  2018,38(1),024-9","journal-title":"J Coloproctol (Rio J)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"Dekker E.","year":"2019","unstructured":"Dekker E.; Tanis P.J.; Vleugels J.L.A.; Kasi P.M.; Wallace M.B.; Colorectal cancer. Lancet  2019,394(10207),1467-1480","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.3892\/ol.2018.7887","volume":"15","author":"Buschauer S.","year":"2018","unstructured":"Buschauer S.; Koch A.; Wiggermann P.; M\u00fcller M.; Hellerbrand C.; Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro. Oncol Lett  2018,15(4),4635-4640","journal-title":"Oncol Lett"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.3390\/molecules27238504","volume":"27","author":"Okasha H.","year":"2022","unstructured":"Okasha H.; Aboushousha T.; Coimbra M.A.; Cardoso S.M.; Ghareeb M.A.; Metabolite profiling of Alocasia gigantea leaf extract and its potential anticancer effect through autophagy in hepatocellular carcinoma. Molecules  2022,27(23),8504","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1872208317666230512143508","volume":"7","author":"Okasha H.","year":"2023","unstructured":"Okasha H.; Fundamental uses of peptides as a new model in both treatment and diagnosis. Recent Pat Biotechnol  2023,7,1-18","journal-title":"Recent Pat Biotechnol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/or.2017.5778","volume":"38","author":"Wang L.","year":"2017","unstructured":"Wang L.; Dong C.; Li X.; Han W.; Su X.; Anticancer potential of bioactive peptides from animal sources. Oncol Rep  2017,38(2),637-651","journal-title":"Oncol Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1093\/bioinformatics\/bty451","volume":"34","author":"Wei L.","year":"2018","unstructured":"Wei L.; Zhou C.; Chen H.; Song J.; Su R.; ACPred-FL: A sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides. Bioinformatics  2018,34(23),4007-4016","journal-title":"Bioinformatics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.2174\/1573407216666200206095954","volume":"16","author":"Morsi E.A.","year":"2020","unstructured":"Morsi E.A.; Ahmed H.O.; Abdel-Hady H.; El-Sayed M.; Shemis M.A.; GC-analysis, and antioxidant, anti-inflammatory, and anticancer activities of some extracts and fractions of Linum usitatissimum. Curr Bioact Compd  2020,16(9),1306-1318","journal-title":"Curr Bioact Compd"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1038\/s41598-020-69995-9","volume":"10","author":"Greco I.","year":"2020","unstructured":"Greco I.; Molchanova N.; Holmedal E.; Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep  2020,10(1),13206","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.26452\/ijrps.v10i4.1574","volume":"10","author":"Hend O.","year":"2019","unstructured":"Hend O.; Marwa H.; Tarek A.; Safia S.; Effect of Interferon-Beta (IFN-\u03b2) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line. Int J Res Pharm Sci  2019,10(4),2936-2943","journal-title":"Int J Res Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1872208314666201112105053","volume":"15","author":"Saber M.A.","year":"2021","unstructured":"Saber M.A.; Okasha H.; Khorshed F.; Samir S.; A novel cell-based in vitro assay for antiviral activity of Interferons \u03b1, \u03b2, and \u03b3 by qPCR of MxA gene expression. Recent Pat Biotechnol  2021,15(1),67-75","journal-title":"Recent Pat Biotechnol"},{"key":"ref=23","first-page":"356","volume":"15","author":"Golestani E.B.","year":"2014","unstructured":"Golestani E.B.; Sanati M.H.; Houshmand M.; Ataei M.; Akbarian F.; Shakhssalim N.; Expression and prognostic significance of bcl-2 and bax in the progression and clinical outcome of transitional bladder cell carcinoma. Cell J  2014,15(4),356-363","journal-title":"Cell J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15171\/jlms.2019.26","volume":"10","author":"Khoshsirat S.","year":"2019","unstructured":"Khoshsirat S.; Abbaszadeh H.A.; Khoramgah M.S.; Protective effect of photobiomodulation therapy and bone marrow stromal stem cells conditioned media on pheochromocytoma cell line 12 against oxidative stress induced by hydrogen peroxide. J Lasers Med Sci  2019,10(3),163-170","journal-title":"J Lasers Med Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6121328","volume":"2018","author":"Yuan Y.G.","year":"2018","unstructured":"Yuan Y.G.; Zhang S.; Hwang J.Y.; Kong I.K.; Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells. Oxid Med Cell Longev  2018,2018,1-21","journal-title":"Oxid Med Cell Longev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cogc.2014.12.004","volume":"7","author":"Borhani N.","year":"2014","unstructured":"Borhani N.; Manoochehri M.; Saleh G.S.; Ghaffari Novin M.; Mansouri A.; Omrani M.D.; Decreased expression of proapoptotic genes caspase-8- and BCL2-associated agonist of cell death (BAD) in ovarian cancer. Clin Ovarian Gynecol Cancer  2014,7(1-2),18-23","journal-title":"Clin Ovarian Gynecol Cancer"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1002\/cam4.2440","volume":"8","author":"Song C.","year":"2019","unstructured":"Song C.; Han Y.; Luo H.; HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer. Cancer Med  2019,8(12),5651-5661","journal-title":"Cancer Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"128637","DOI":"10.1016\/j.ijbiomac.2023.128637","volume":"257","author":"Nasr S.M.","year":"2024","unstructured":"Nasr S.M.; Samir S.; Okasha H.; Interdisciplinary gene manipulation, molecular cloning, and recombinant expression of modified human growth hormone isoform-1 in E. coli system. Int J Biol Macromol  2024,257(Pt 1),128637","journal-title":"Int J Biol Macromol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncy.22383","volume":"129","author":"Koomen B.M.","year":"2021","unstructured":"Koomen B.M.; van der Starre-Gaal J.; Vonk J.M.; Formalin fixation for optimal concordance of programmed death\u2010ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer. Cancer Cytopathol  2021,129(4),304-317","journal-title":"Cancer Cytopathol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","volume":"57","author":"Chiangjong W.","year":"2020","unstructured":"Chiangjong W.; Chutipongtanate S.; Hongeng S.; Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review). Int J Oncol  2020,57(3),678-696","journal-title":"Int J Oncol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3389\/fimmu.2017.01320","volume":"8","author":"Roudi R.","year":"2017","unstructured":"Roudi R.; Syn N.L.; Roudbary M.; Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: A comprehensive overview. Front Immunol  2017,8,1320","journal-title":"Front Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","volume":"110-111","author":"Ruoslahti E.","year":"2017","unstructured":"Ruoslahti E.; Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev  2017,110-111,3-12","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fonc.2013.00216","volume":"3","author":"Teesalu T.","year":"2013","unstructured":"Teesalu T.; Sugahara K.N.; Ruoslahti E.; Tumor-penetrating peptides. Front Oncol  2013,3,216","journal-title":"Front Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-801238-3.04040-X","author":"Kumar D.","year":"2014","unstructured":"Kumar D.; Eipper B.A.; Mains R.E.;  Amidation Reference Module in Biomedical Sciences  2014,1-5","journal-title":"Amidation Reference Module in Biomedical Sciences"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"Xie M.","year":"2020","unstructured":"Xie M.; Liu D.; Yang Y.; Anti-cancer peptides: Classification, mechanism of action, reconstruction and modification. Open Biol  2020,10(7),200004","journal-title":"Open Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/bs.apcsb.2014.11.002","author":"Kouchakzadeh H.","year":"2015","unstructured":"Kouchakzadeh H.; Safavi M.S.; Shojaosadati S.A.;  Protein and peptide nanoparticles for drug delivery  2015,98","journal-title":"Protein and peptide nanoparticles for drug delivery"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.3390\/ijms22168828","volume":"22","author":"Pandey S.","year":"2021","unstructured":"Pandey S.; Malviya G.; Chottova D.M.; Role of peptides in diagnostics. Int J Mol Sci  2021,22(16),8828","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3390\/molecules25184298","volume":"25","author":"Capasso D.","year":"2020","unstructured":"Capasso D.; Del Gatto A.; Comegna D.; Selective targeting of \u03b1v\u03b25 integrin in HepG2 cell line by RGDechi15D peptide. Molecules  2020,25(18),4298","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"Holohan C.","year":"2013","unstructured":"Holohan C.; Van Schaeybroeck S.; Longley D.B.; Johnston P.G.; Cancer drug resistance: An evolving paradigm. Nat Rev Cancer  2013,13(10),714-726","journal-title":"Nat Rev Cancer"},{"key":"ref=40","author":"Christian A.","year":"2021","unstructured":"Christian A.;  Rgd-containing peptide and use thereof for cancer treatment WO2021185719A1 WIPO  2021","journal-title":"Rgd-containing peptide and use thereof for cancer treatment WO2021185719A1 WIPO"}],"container-title":["Recent Patents on Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118722083300452240315035722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228169\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118722083300452240315035722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:19:58Z","timestamp":1733728798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228169\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118722083300452240315035722","relation":{},"ISSN":["1872-2083"],"issn-type":[{"value":"1872-2083","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}